These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cardiometabolic features of polycystic ovary syndrome. Hoffman LK, Ehrmann DA. Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):215-22. PubMed ID: 18250636 [Abstract] [Full Text] [Related]
7. [Long-term risks of polycystic ovaries syndrome]. Lefebvre P, Raingeard I, Renard E, Bringer J. Gynecol Obstet Fertil; 2004 Mar; 32(3):193-8. PubMed ID: 15123116 [Abstract] [Full Text] [Related]
8. Cardiovascular health in women with polycystic ovary syndrome. Sukalich S, Guzick D. Semin Reprod Med; 2003 Aug; 21(3):309-15. PubMed ID: 14593554 [Abstract] [Full Text] [Related]
9. Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome. Cattrall FR, Healy DL. Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):803-12. PubMed ID: 15380148 [Abstract] [Full Text] [Related]
10. Metabolic and vascular abnormalities in subjects at risk for type 2 diabetes: the early start of a dangerous situation. Caballero AE. Arch Med Res; 2005 Oct; 36(3):241-9. PubMed ID: 15925014 [Abstract] [Full Text] [Related]
15. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance. Bethea SW, Nestler JE. Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870 [Abstract] [Full Text] [Related]
16. Obesity and the polycystic ovary syndrome. Magnotti M, Futterweit W. Med Clin North Am; 2007 Nov; 91(6):1151-68, ix-x. PubMed ID: 17964914 [Abstract] [Full Text] [Related]
18. Cardiovascular risk in women with polycystic ovary syndrome. Giallauria F, Orio F, Palomba S, Lombardi G, Colao A, Vigorito C. J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960 [Abstract] [Full Text] [Related]
19. Cardiovascular risk in women with polycystic ovary syndrome. Cho LW, Atkin SL. Minerva Endocrinol; 2007 Dec; 32(4):263-73. PubMed ID: 18091663 [Abstract] [Full Text] [Related]
20. Cardiovascular risk factors are reduced with a low dose of acarbose in obese patients with polycystic ovary syndrome. Araujo Penna I, Canella PR, Vieira CS, Silva de Sá MF, dos Reis RM, Ferriani RA. Fertil Steril; 2007 Aug; 88(2):519-22. PubMed ID: 17418836 [Abstract] [Full Text] [Related] Page: [Next] [New Search]